TY - JOUR
AR - JCMCR-2020-2-105
TI - The Clinical and Treatment Challenges Posed by COVID-19
AU - James, Pandarakalam
JO - Journal of Clinical and Medical Case Reports
PY - 2020
DA - Thu 09, Jul 2020
SN - 2733-2268
DO - http://dx.doi.org/10.31487/j.JCMCR.2020.02.05
UR - https://www.sciencerepository.org/the-clinical-and-treatment-challenges-posed-by-covid-19_JCMCR-2020-2-105 
KW - Antiviral drugs, COVID-19, pneumonia, pathogenesis, virology, immune response
AB - Medical profession was unprepared to face the corona virus pandemic and the pharmaceutical
armamentarium is currently not robust enough to combat with SARS-CoV-2. Drugs that are used for other
medical conditions are also on trial to treat COVID-19. The pandemic is bound to pose psychological and
economical sufferings. Testing, treatments and vaccine are the three tools to combat with COVID-19. It is
feared that this viral infection would lead to an amplification of existing mental health issues and result in
a surge of cases of PTSD and depression. Senior citizens and people with compromised immunity becomes
more vulnerable to this toxic pathogen. A sound knowledge of all aspects of COVID-19 becomes essential
to deal with the aftermaths of this unprecedented pandemic and mental health professionals will have to
refresh their knowledge of virology and immunology. All the medical specialities will have to work together
to defeat the novel virus.